August 1, 2022 Miscellaneous

Protocol: Alliance – A151804

SCHEMA A151804

Please Note: Below is partial eligibility, for full eligibility requirement’s, please contact GHCI Research Department at (810) 762-8181, (810) 762-8079 and/or (810) 762-8038. Thank you!


  1. Planning to receive a regimen containing one or more immuno-oncology (IO) therapeutics. Note: Contact GHCI Research Dept., to discuss allowable therapeutic agents.
  2. Has not previously been treated with CTLA-4, PD-1 or PD-L1 inhibitors.
  3. Willing and able to provide baseline blood and stool samples.


  1. Receiving one or more of the allowed therapeutic agents.
  2. Experienced one or more serious AEs.

Genesys Hurley Cancer Institute

302 Kensington Avenue (Print a Map)
Flint, MI 48503

810-762-8226 | 888-762-8675

Ascension Genesys Hospital
Hurley Medical Center
Michigan Cancer Consortium


Ⓒ 2020 Genesys Hurley Cancer Institute | All Rights Reserved.